Members

About GENinCode

GENinCode US is an Irvine, CA based company specializing in genetic risk assessment and prevention of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, Europe through GENinCode S.L.U, and in the United States through GENinCode U.S. Inc. GENinCode’s predictive technology provides patients and physicians with globally leading preventive care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict and prevent cardiovascular disease.

Contact Information:
genincode.com

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.

Contact Information:
www.illumina.com

About Rocket Pharma

Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Rocket’s innovative multi-platform approach and world-class pipeline of AAV cardiovascular and LV hematology programs allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable people living with devastating rare diseases to experience long and full lives. For more information about Rocket, visit www.rocketpharma.com and follow us on LinkedIn, YouTube and X.

Through our Mission: Genome program, we are committed to helping clinicians and their patients with genetic cardiomyopathies by educating on the use of genetic testing, removing barriers to counseling and testing, and supporting earlier diagnoses and access to care. For more, visit www.missiongenome.com.

Contact Information:
Website: www.rocketpharma.com